Are you Dr. Krishnamurthy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Savitri Krishnamurthy, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, California, and Massachusetts. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 1998 - 1999
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1997 - 1998
Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Medical College and Hospital KolkataClass of 1986
Certifications & Licensure
CA State Medical License 2004 - 2026
TX State Medical License 1999 - 2026
MA State Medical License 1997 - 2008- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue. Start of enrollment: 2020 Aug 03
Publications & Presentations
PubMed
- 1 citationsTrichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohis...Deepak Donthi, Qiong Gan, Qing Qing Ding, Savitri Krishnamurthy
Cancer Cytopathology. 2024-12-01 - Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.Melissa P Mitchell, Simona F Shaitelman, Benjamin D Smith, Savitri Krishnamurthy, Vicente Valero
European Journal of Surgical Oncology. 2024-12-01 - Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer.Xiaoping Wang, Li Zhao, Xingzhi Song, Xiaogang Wu, Savitri Krishnamurthy
NPJ Precision Oncology. 2024-11-18
Press Mentions
MD Anderson Research Highlights for October 16, 2024October 16th, 2024- International Multi-Site Study of Ibex Medical Analytics’ AI-Powered Solution Demonstrates Improved HER2 Biomarker Scoring in Breast CancerOctober 15th, 2024
- MD Anderson Research Highlights for March 29, 2023March 28th, 2023
- Join now to see all
